Catalog Number 1012270-12 |
Device Problems
Material Rupture (1546); Improper or Incorrect Procedure or Method (2017)
|
Patient Problems
Death (1802); Non specific EKG/ECG Changes (1817); Ischemia (1942)
|
Event Date 04/20/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all relevant information.
|
|
Event Description
|
It was reported that the procedure was to treat a de novo lesion located in the diagonal branch with heavy calcification and no tortuosity.The 2.0 x 12 mm mini trek rx was advanced to the lesion and crossed successfully.The balloon was inflated to 8 atmospheres during the first inflation and again to 10 atmospheres for the second inflation when a rupture occurred.It was stated that the balloon was not soaked in saline prior to use.It was reported that st elevation and slow blood flow in the vessel was observed when the balloon ruptured.A new device was used to successfully complete the procedure.There were no adverse patient effects or clinically significant delay in the procedure reported.However, it was reported that the patient expired the next day when awaiting for transfer to surgery to treat a severe aortic stenosis.It was believed that the death was unrelated to the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Evaluation summary: visual and functional inspections were performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other similar incidents from this lot.It should be noted that the mini trek rx, instruction for use, states: submerge the balloon in sterile heparinized normal saline during balloon preparation, to activate the coating.In this case, it is unknown if the ifu violation caused or contributed to the reported complaint.The investigation determined the reported balloon rupture and patient effects/additional treatment appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
|
|
Event Description
|
The following additional information was received: prior to the initial procedure, the patient presented with dyspnea on exertion and syncope.The patient was given medication to treat the reported st elevation and slow blood flow.A 2.25 x 20 mm non-abbott stent was successfully implanted in the target lesion, which resolved the slow flow.The following day, while awaiting treatment of pre-existing aortic stenosis, an attempt was made to implant a permanent pacemaker at which time the patient became bradycardic and hypotensive.It was stated by the physician that the patient died from bradycardic arrest unrelated to the balloon rupture or percutaneous transluminal coronary procedure.Angiography prior to the patient death found no thrombus clots.No additional information was provided.
|
|
Search Alerts/Recalls
|